The $350 central target is calculated from three individually verifiable analyst targets. Deutsche Bank's Scott Deuschle reiterated a Buy rating and raised the target to $413 on August 10, 2026 (from $400). JPMorgan's Tomohiko Sano maintained an Overweight rating but lowered the target to $350 on October 13, 2026 (from $420). Stephens' Tommy Moll set a $300 target with an Overweight rating on February 9, 2026, before the Megger deal closed.
The three figures sum to $1,063, for a mean of roughly $354, which rounds to the $350 central target used throughout this article. The range of $300 to $413 is wide, and it underscores a genuine disagreement: bulls see the Megger integration as a step-change in the utility-testing franchise, while more cautious analysts see acquisition-related financing, amortization, and margin pressure as offsetting near-term benefits. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Independent data providers report slightly different averages (for example, roughly $352.75 across four analysts in one tracker), reflecting different target universes rather than an official consensus.
The stock closed at $223.02 on November 19, 2026, before rising about 5% in after-hours trading to roughly $235 following the fourth-quarter earnings beat. From the $223 close, the move to $350 represents roughly 57% upside, which is a very large required move. That gap also reflects the stock's drawdown: the shares trade well below the 52-week high of $362.15 and above the 52-week low of $193.68.
The path toward $350 would most likely depend on earnings growth continuing after the Megger deal, a rebound in the stock's price-to-earnings (P/E) ratio, and steady margin execution. Fiscal 2026 revenue grew 21% to about $1.32 billion, and adjusted earnings per share (EPS) rose roughly 40% to $8.42. Management guided fiscal 2027 revenue to $2.05 billion to $2.09 billion — a jump of more than 50% that reflects the Megger contribution — with adjusted EPS of $9.40 to $9.70.
The strongest support is demand visibility. Backlog surpassed $1.5 billion, and the combined Navy businesses held a backlog above $770 million, up over 40% year over year. Commercial aerospace sales grew 20% in fiscal 2026, and the RF Shielding and Test segment posted a second straight year of double-digit growth, helped by military, automotive, and U.S. government data-center projects.
The Megger acquisition, completed October 1, 2026, creates "Doble Megger" and materially expands the Utility Solutions Group's international reach in electrical testing, monitoring, and diagnostics. Grid modernization, electrification, and aging infrastructure provide a durable, multi-year demand backdrop. Analysts who carry targets at or above $350 generally cite this growth runway and the record book-to-bill of 1.31 for the full year.
The biggest obstacle is execution risk around integrating the largest deal in company history. Acquisition-related intangible amortization and financing costs were already visible in the fourth quarter, and management has flagged some near-term margin pressure. Weaker results in the renewable-energy portion of the utility business have also weighed on margins.
Valuation is a secondary concern: the trailing P/E ratio near 41 is elevated for an industrial manufacturer, even with strong growth. The stock's fall from its $362 high shows how quickly sentiment can reverse when targets are revised downward — JPMorgan's cut from $420 to $350 is one example. Finally, the wide analyst range itself signals that the higher targets depend on favorable assumptions about the acquisition paying off.
On a longer-term basis, the $193.68 52-week low is the key support level below the current price. The $223 area is near the lower-middle of the year's range. Resistance sits first near the round-number $300 level — which coincides with the Stephens target — and then at the $362 52-week high. A sustained move toward $350 would likely need to reclaim $300 first and hold it, given how far the stock has corrected from its peak.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual assumptions vary. Investors should watch the first quarters of Megger integration, including margin trajectory, debt levels, and whether fiscal 2027 guidance is reaffirmed or raised. Other items to monitor include Navy order flow and backlog, commercial aerospace build rates, data-center and military demand in the Test segment, any further analyst target revisions, and interest-rate conditions, which affect both financing costs and the valuation multiple applied to a growth-oriented industrial.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. For traders, this can help surface opportunities, track existing positions, and identify changing trends more efficiently than manual screening. As you evaluate ESE and the broader market outlook, these automated signals can serve as one additional input alongside fundamental research. In my view, running ESE through these tools regularly provides a useful cross-check on the fundamental story.
The $350 target is a calculated average of three verifiable analyst price targets, not a guarantee, and it sits roughly 57% above the latest close. The bullish case rests on record results, a transformative acquisition, and exceptional backlog visibility, while the bearish case centers on integration risk, acquisition-related costs, a premium valuation, and a wide range of analyst views that span from $300 to $413. Whether the stock reaches $350 will depend above all on whether the Megger integration preserves margins while converting record demand into sustained earnings growth. From what I see, the coming quarters will be decisive.
I regularly turn to Tickeron’s AI Daily Buy/Sell Signals when scanning for confirmation on names like ESE. The platform’s AI-driven alerts help me stay objective and spot shifts faster than manual review alone. It has become a practical part of my routine for balancing fundamentals with technical signals without adding much extra time to the process.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Aroon Indicator for ESE entered a downward trend on November 03, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 152 similar instances where the Aroon Indicator formed such a pattern. In 88 of the 152 cases the stock moved lower. This puts the odds of a downward move at 58%.
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ESE as a result. In 50 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.
The Moving Average Convergence Divergence Histogram (MACD) for ESE turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 26 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ESE's RSI Oscillator exited the oversold zone, 14 of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +6.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where ESE advanced for three days, in 213 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
ESE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. ESE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.691) is normal, around the industry mean (1.448). P/E Ratio (18.917) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (12.750) is also within normal values, averaging (5.470). Dividend Yield (0.001) settles around the average of (0.012) among similar stocks. P/S Ratio (5.208) is also within normal values, averaging (32.028).
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of engineering products and systems
Industry ElectronicEquipmentInstruments